Purple Biotech Accounts Payable

Purple Biotech (PPBT) currently reports a accounts payable of $840K as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Purple Biotech's accounts payable history and peer comparisons.

Purple Biotech's accounts payable changed from $0 to $840K (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Purple Biotech reported $840K in accounts payable as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $840K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Purple Biotech, and consider following PPBT for alerts when major investors trade the stock.

Purple Biotech is classified in the Healthcare sector. On accounts payable, it currently shows $840K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PPBT with unrelated industries.